A detailed history of Acadian Asset Management LLC transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 882,262 shares of HOOK stock, worth $564,647. This represents 0.0% of its overall portfolio holdings.

Number of Shares
882,262
Previous 474,730 85.85%
Holding current value
$564,647
Previous $383,000 63.71%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.61 - $0.83 $248,594 - $338,251
407,532 Added 85.85%
882,262 $627,000
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.86 $19,478 - $39,884
46,377 Added 10.83%
474,730 $383,000
Q2 2023

Aug 07, 2023

SELL
$0.71 - $1.97 $180,337 - $500,372
-253,996 Reduced 37.22%
428,353 $375,000
Q1 2023

May 11, 2023

BUY
$0.72 - $1.03 $27,906 - $39,921
38,759 Added 6.02%
682,349 $500,000
Q4 2022

Feb 14, 2023

BUY
$0.73 - $1.31 $416,251 - $746,972
570,208 Added 777.04%
643,590 $520,000
Q3 2022

Nov 14, 2022

BUY
$1.27 - $1.87 $93,195 - $137,224
73,382 New
73,382 $97,000
Q2 2022

Aug 09, 2022

SELL
$1.33 - $2.31 $29,898 - $51,928
-22,480 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$1.26 - $2.52 $289,517 - $579,035
-229,776 Reduced 91.09%
22,480 $51,000
Q4 2021

Feb 10, 2022

BUY
$2.33 - $5.94 $398,474 - $1.02 Million
171,019 Added 210.52%
252,256 $587,000
Q3 2021

Nov 12, 2021

BUY
$5.89 - $9.35 $131,776 - $209,187
22,373 Added 38.01%
81,237 $477,000
Q2 2021

Aug 11, 2021

BUY
$9.16 - $19.51 $539,194 - $1.15 Million
58,864 New
58,864 $539,000

Others Institutions Holding HOOK

About HOOKIPA Pharma Inc.


  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $33.1M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.